Sang Gyune Kim: Clinical Trials

2 trials sponsored by Sang Gyune Kim, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1

Follow Sang Gyune Kim: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for Paracentesis
KARAHOC device, Angiocatheter - Ascites Hepatic
Not applicableUnknownSang Gyune Kim802022-01-172022-10-13
Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment
Daclatasvir and Asunaprevir - Chronic Hepatitis C
UnknownSang Gyune Kim1032016-09-012017-03-07

Conditions studied

Fibrosis (2)  ·  Ascites (1)  ·  Hepatitis C, Chronic (1)

Interventions

asunaprevir (1)  ·  daclatasvir (1)

Countries

South Korea (2)

Results publications

PMID 34996920, PMID 42693590